Cantitate/Preț
Produs

Normal and Malignant Hematopoiesis: New Advances: Pezcoller Foundation Symposia, cartea 6

Editat de Enrico Mihich, Donald Metcalf
en Limba Engleză Paperback – 21 noi 2012
''An exciting glance at key issues in contemporary hematopoiesis.'' -The Quarterly Review of Biology
Citește tot Restrânge

Din seria Pezcoller Foundation Symposia

Preț: 37038 lei

Preț vechi: 38988 lei
-5% Nou

Puncte Express: 556

Preț estimativ în valută:
7087 7400$ 5852£

Carte tipărită la comandă

Livrare economică 15-29 aprilie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781461357896
ISBN-10: 1461357896
Pagini: 260
Ilustrații: X, 249 p.
Dimensiuni: 178 x 254 x 14 mm
Greutate: 0.46 kg
Ediția:Softcover reprint of the original 1st ed. 1995
Editura: Springer Us
Colecția Springer
Seria Pezcoller Foundation Symposia

Locul publicării:New York, NY, United States

Public țintă

Research

Cuprins

1. Regulation of Normal Hemopoiesis.- 2. Cytokine Regulation of Lymphohemopoietic Progenitors.- 3. Hematopoietic Stem Cells.- 4. Transcriptional Control of Hematopoietic Development: Roles of GATA-Factors.- 5. Rearrangement of the ALL1 Gene in Acute Myeloid Leukemia without Chromosomal Translocations.- 6. Non-Receptor Protein Tyrosine Kinases: Pivotal Regulatory Molecules Controlling Lymphopoiesis.- 7. The Regulation and Function of p21Ras in T Cell Activation and Growth.- 8. Irf-1 Functions as a Tumor Suppressor: Possible Involvement in Human Myelodysplasia and Leukemia.- 9. A Family of High Molecular Weight Proteins Active in Differentiation and Growth Control.- 10. Hematopoietic Signaling by the Cytokine Receptor Superfamily.- 11. Positive and Negative Growth Effects of Abl Genes.- 12. Advances in the Understanding of the Molecular Pathogenesis of Aggressive B Cell Lymphomas.- 13. Structure and Expression Pattern of the PML Gene.- 14. Contribution of the Cyclin D1 Gene to Lymphomagenesis.- 15. Clinical Results of All-trans Retinoic Acid: A Targeted Drug for Differentiation Treatment in Acute Promyelocytic Leukemia.- 16. Induction of Alloantigen Specific T Cell Anergy by Inhibition of the B7:CD28 Pathway.- 17. Novel Strategies for Cancer Treatment through Modulation of Proimmune and Proinflammatory Cytokines.- 18. Concluding Comments.